The Annexure

Desk› Symbiotec Pharmalab Ltd

No classification yet. This company listed after the last monthly reference refresh; its tiers fill in on the next one.

Symbiotec Pharmalab Ltd

BSE 544889

Disclosure profile 4 filings in the window

TagFilings
Procedural
General2
New Listing1
Trading Window1
Procedural sub-total4
Total4

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group —, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 65 trading days

4 filings · 0 selected · busiest 2026-09-01

Filing rhythm · the twelve most recent

2026-09-012026-09-01

SelectedProcedural

Filings

4 in the window

  1. 1 September 2026

    New Listing

    Listing of Equity Shares of Symbiotec Pharmalab Ltd

    Trading Members of the Exchange are hereby informed that effective from September 01, 2026, the Equity Shares of Symbiotec Pharmalab Ltd (Scrip Code: 544889) are listed and admitted to ....

    New Listing / New Listing

  2. 1 September 2026

    General

    Disclosure Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

    Disclosure regarding authority to determine materiality of event or information.

    Company Update / General View filing →

  3. 1 September 2026

    General

    Intimation Under Regulation 8(2) Of The Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015.

    Intimation under Regulation 8(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

    Company Update / General View filing →

  4. 1 September 2026

    Trading Window

    Closure of Trading Window

    Closure of trading window for the quarter ended June 30, 2026.

    Insider Trading / SAST / Closure of Trading Window View filing →